These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10507494)

  • 1. A commentary on a randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients.
    Korvick JA; Elashoff MR; Cavaillé-Coll M
    Transplantation; 1999 Sep; 68(5):708-9. PubMed ID: 10507494
    [No Abstract]   [Full Text] [Related]  

  • 2. Mycophenolate mofetil (RS-61443): preclinical, clinical, and three-year experience in heart transplantation.
    Taylor DO; Ensley RD; Olsen SL; Dunn D; Renlund DG
    J Heart Lung Transplant; 1994; 13(4):571-82. PubMed ID: 7947873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of mycophenolate mofetil in heart transplant recipients.
    Seebacher G; Mallinger R; Laufer G; Grimm M; Griesmacher A; Weigel G; Wolner E; Müller MM
    Adv Exp Med Biol; 1998; 431():801-3. PubMed ID: 9598174
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term benefits of mycophenolate mofetil after heart transplantation.
    Keogh A
    Transplantation; 2005 Feb; 79(3 Suppl):S45-6. PubMed ID: 15699750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New immunosuppressive agents in clinical use: mycophenolate mofetil and tacrolimus.
    Hunt SA
    Cardiol Rev; 2000; 8(3):180-4. PubMed ID: 11174892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a mycophenolate mofetil-based immunosuppressive regimen in Chagas' heart transplant recipients.
    Bestetti RB; Souza TR; Lima MF; Theodoropoulos TA; Cordeiro JA; Burdmann EA
    Transplantation; 2007 Aug; 84(3):441-2. PubMed ID: 17700175
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of inosine monophosphate dehydrogenase activity by the plasma of heart transplant recipients receiving mycophenolate mofetil.
    Griesmacher A; Weigel G; Seebacher G; Mallinger R; Laufer G; Müller MM
    Adv Exp Med Biol; 1998; 431():537-41. PubMed ID: 9598124
    [No Abstract]   [Full Text] [Related]  

  • 8. Primary immunosuppression with tacrolimus and mycophenolate mofetil versus cyclosporine and azathioprine in heart transplant recipients.
    Teebken OE; Strüber M; Harringer W; Pichlmaier MA; Haverich A
    Transplant Proc; 2002 Jun; 34(4):1265-8. PubMed ID: 12072335
    [No Abstract]   [Full Text] [Related]  

  • 9. Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil--a prospective randomized study. Steroid Withdrawal Study Group.
    Ahsan N; Hricik D; Matas A; Rose S; Tomlanovich S; Wilkinson A; Ewell M; McIntosh M; Stablein D; Hodge E
    Transplantation; 1999 Dec; 68(12):1865-74. PubMed ID: 10628766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycophenolate mofetil monotherapy in patients who have had kidney transplants.
    Land W
    Transplantation; 2003 Jun; 75(12):2159. PubMed ID: 12829933
    [No Abstract]   [Full Text] [Related]  

  • 11. Mycophenolate mofetil in IgA nephropathy.
    Sepe V; Rossi N; Adamo G; Dal Canton A
    Kidney Int; 2004 Oct; 66(4):1713; author reply 1713-4. PubMed ID: 15458475
    [No Abstract]   [Full Text] [Related]  

  • 12. Mycophenolate mofetil reduces anti-HLA antibody production and cellular rejection in heart transplant recipients.
    Lietz K; John R; Schuster M; Ankersmit J; Burke E; Suciu-Foca N; Edwards N; Mancini D; Itescu S
    Transplant Proc; 2002 Aug; 34(5):1828-9. PubMed ID: 12176593
    [No Abstract]   [Full Text] [Related]  

  • 13. Randomized trial of tacrolimus in combination with mycophenolate mofetil versus cyclosporine with mycophenolate mofetil in cadaveric renal transplant recipients with delayed graft function.
    Liu B; Lin ZB; Ming CS; Zhang WJ; Chen ZS; Sha B; Zeng FJ; Chen S
    Transplant Proc; 2003 Feb; 35(1):87-8. PubMed ID: 12591319
    [No Abstract]   [Full Text] [Related]  

  • 14. Benefits of mycophenolate mofetil in cardiac transplant recipients with cyclosporine-induced nephropathy.
    Sánchez V; Delgado JF; Blasco T; Dalmau R; Morales JM; Escribano P; Tello R; Hernández J; Velázquez T; Sotelo T; Gómez-Sánchez MA; Sáenz de la Calzada C
    Transplant Proc; 1999 Sep; 31(6):2515-6. PubMed ID: 10500695
    [No Abstract]   [Full Text] [Related]  

  • 15. A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Mycophenolate Mofetil Investigators.
    Kobashigawa J; Miller L; Renlund D; Mentzer R; Alderman E; Bourge R; Costanzo M; Eisen H; Dureau G; Ratkovec R; Hummel M; Ipe D; Johnson J; Keogh A; Mamelok R; Mancini D; Smart F; Valantine H
    Transplantation; 1998 Aug; 66(4):507-15. PubMed ID: 9734496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evolving role of mycophenolate mofetil in renal transplantation.
    Warrens AN
    QJM; 2000 Jan; 93(1):15-20. PubMed ID: 10623777
    [No Abstract]   [Full Text] [Related]  

  • 17. Similar efficacy and safety of enteric-coated mycophenolate sodium (EC-MPS, myfortic) compared with mycophenolate mofetil (MMF) in de novo heart transplant recipients: results of a 12-month, single-blind, randomized, parallel-group, multicenter study.
    Kobashigawa JA; Renlund DG; Gerosa G; Almenar L; Eisen HJ; Keogh AM; Lehmkuhl HB; Livi U; Ross H; Segovia J; Yonan N;
    J Heart Lung Transplant; 2006 Aug; 25(8):935-41. PubMed ID: 16890114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of mycophenolate mofetil in immunosuppressive protocols in elderly renal transplant recipients.
    Johnson DW; Nicol DL; Preston JM; Brown AM; Hawley CM; Campbell SB; Wall D; Griffin AD; Isbel NM
    Transplantation; 2003 Aug; 76(3):619. PubMed ID: 12923455
    [No Abstract]   [Full Text] [Related]  

  • 19. Tolerability of mycophenolate mofetil in organ transplant recipients.
    Schweizer RT; Meisterling LD
    Transplant Proc; 2001 May; 33(3):2309. PubMed ID: 11377540
    [No Abstract]   [Full Text] [Related]  

  • 20. Review of major clinical trials with mycophenolate mofetil in cardiac transplantation.
    Kobashigawa JA; Meiser BM
    Transplantation; 2005 Oct; 80(2 Suppl):S235-43. PubMed ID: 16251856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.